Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher risk myelodysplastic syndromes.
Times cited: 43
Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: A phase 1 trial.
Leukemia and Lymphoma.
Times cited: 39